Prognostic value of sST2 in heart failure patients with diabetes

被引：0
|
作者：
Castiglione, V. [1 ]
Chiriaco, M. [1 ]
Aimo, A. [1 ]
Januzzi, J. [2 ]
Richards, A. M. [3 ]
Lam, C. S. P. [4 ]
Latini, R. [5 ]
Anand, I. S. [6 ]
Ueland, T. [7 ]
Brunner-La Rocca, H. P. [8 ]
Bayes-Genis, A. [9 ]
De Boer, R. A. [10 ]
Huber, K. [11 ]
Emdin, M. [1 ]
Vergaro, G. [12 ]
机构：
[1] Inst Life Sci, SantAnna Sch Adv Studies, Pisa, Italy
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Univ Otago Christchurch, Christchurch, New Zealand
[4] Singapore Gen Hosp, Singapore, Singapore
[5] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy
[6] Univ Minnesota, Minneapolis, MN USA
[7] Univ Oslo, Oslo, Norway
[8] Maastricht Univ Med Ctr MUMC, Maastricht, Netherlands
[9] Germans Trias & Pujol Univ Hosp, Barcelona, Spain
[10] Univ Med Ctr Groningen, Groningen, Netherlands
[11] Wilhelminen Hosp, Vienna, Austria
[12] Fdn Toscana Gabriele Monasterio, Pisa, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [21] The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients
    Traxler, Denise
    Zimmermann, Matthias
    Simader, Elisabeth
    Veraar, Cecilia M.
    Moser, Bernhard
    Mueller, Thomas
    Mildner, Michael
    Dannenberg, Varius
    Lainscak, Mitja
    Jug, Borut
    Ankersmit, Hendrik J.
    CLINICA CHIMICA ACTA, 2020, 510 : 507 - 514
  • [22] Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
    Podzolkov, V., I
    Dragomiretskaya, N. A.
    Tolmacheva, A., V
    Shvedov, I. I.
    Ivannikov, A. A.
    Yu, Akyol, V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (04) : 310 - 319
  • [23] sST2 and Heart Failure-Clinical Utility and Prognosis
    Dudek, Magdalena
    Kaluzna-Oleksy, Marta
    Migaj, Jacek
    Sawczak, Filip
    Krysztofiak, Helena
    Lesiak, Maciej
    Straburzynska-Migaj, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [24] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
    Pan, Wei
    Yang, Donghui
    Yu, Peng
    Yu, Huizhen
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [25] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
    Wei Pan
    Donghui Yang
    Peng Yu
    Huizhen Yu
    BMC Cardiovascular Disorders, 20
  • [26] sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure, independent of Mineralocorticoid Receptor Antagonists treatment
    Barutaut, M.
    Fournier, P.
    Peacock, W. F.
    Dambrin, C.
    Caubere, C.
    Servoz, C.
    Koukoui, F.
    Galinier, M.
    Smih, F.
    Rouet, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 241 - 242
  • [27] Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction
    Huang, Anan
    Qi, Xin
    Hou, Wenguang
    Qi, Yanfang
    Zhao, Na
    Liu, Keqaing
    ACTA CARDIOLOGICA, 2018, 73 (01) : 41 - 48
  • [28] The ssT2 level in prediction of heart failure decompensation in patients with acute myocardial infarction
    Rodionova, I. Iulia
    Hylova, Y. V.
    Kutya, I.
    Kopytsya, M. P.
    Kobets, A. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 384 - 384
  • [29] The biological variability of sST2, a novel serum biomarker for heart failure
    Wu, A.
    Snider, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S299 - S299
  • [30] Serum Cat S, TSP-1, IL-11, BNP and sST2 Diagnostic and Prognostic Value in Chronic Heart Failure
    Xiang, Yang
    Zhang, Zhixin
    Xie, Cui
    Wang, Lin
    Wu, You
    Zhan, Yu
    Chen, Dan
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2022, 28 (04) : 55 - 59
12345